Today: 7 February 2026
Subscribe
Browse Category

Stock Analysis News 11 December 2025

Western Digital (WDC) Stock Outlook After November 21, 2025: AI Storage Boom, ESOP Shelf Offering and Wall Street Price Targets

Western Digital (WDC) Stock Outlook After November 21, 2025: AI Storage Boom, ESOP Shelf Offering and Wall Street Price Targets

Western Digital Corporation (NASDAQ: WDC) has become one of 2025’s most dramatic AI infrastructure winners. The hard‑disk drive (HDD) specialist, now a pure play on enterprise and cloud storage after spinning off its Flash business into SanDisk earlier this year, has seen its share price soar more than 200% over the last 12 months as AI‑driven data demand explodes. Western Digital+2Trefis+2 Since November 21, 2025, the stock has moved through a volatile but largely upward phase, shaped by AI‑focused product launches, a sizable employee stock ownership plan (ESOP) shelf registration, and a wave of fresh analyst upgrades and fair‑value models.
11 December 2025
····
Extreme Networks (EXTR) Stock Forecast: Analyst Targets, 2026 Guidance and Institutional Flows as of December 11, 2025

Extreme Networks (EXTR) Stock Forecast: Analyst Targets, 2026 Guidance and Institutional Flows as of December 11, 2025

Extreme Networks, Inc. (NASDAQ: EXTR), the cloud‑driven networking vendor behind the ExtremeCloud IQ and Platform ONE portfolio, is back in the spotlight as investors digest fresh guidance, bullish analyst calls and a new wave of institutional activity.Wikipedia+1 As of December 11, 2025, EXTR is trading around $17.3–$17.4 per share, down roughly 4–5% on the day, with a 52‑week range of $10.10 to $22.89 and a market capitalization of about $2.3 billion.StockAnalysis That leaves the stock more than 70% above its 52‑week low, but still about 24% below its high, a classic “mid‑range” setup where the narrative matters as much as
11 December 2025
·····
Semiconductor Stocks Sink as Oracle Revives AI Bubble Fears — Nvidia, AMD, Micron in the Spotlight on December 11, 2025

Semiconductor Stocks Sink as Oracle Revives AI Bubble Fears — Nvidia, AMD, Micron in the Spotlight on December 11, 2025

U.S. chip stocks came under heavy pressure on Thursday, December 11, 2025, as investors digested a cocktail of AI bubble worries, fresh Federal Reserve policy signals, and new geopolitical twists in the semiconductor trade. By late morning in New York, the tech‑heavy Nasdaq was down about 1%, even as the Dow Jones Industrial Average hit a new intraday record, with the weakness centered squarely on AI‑exposed technology and semiconductor names.Investopedia The Philadelphia Semiconductor Index (SOX) fell roughly 2%, with Nvidia, AMD, Micron, Broadcom and other chipmakers sliding between about 3% and 4%.Reuters+1 At the heart of the sell‑off: Oracle’s earnings and
11 December 2025
···········
SharpLink Gaming (SBET) Stock in December 2025: Ethereum Treasury Giant at a Discount After 2,600% Spike and 86% Crash

SharpLink Gaming (SBET) Stock in December 2025: Ethereum Treasury Giant at a Discount After 2,600% Spike and 86% Crash

SharpLink Gaming, Inc. (NASDAQ: SBET) has become one of the wildest stories on the public markets in 2025: a former sports-betting tech company that turned itself into an Ethereum treasury vehicle, rocketed more than 2,600%… and then gave back roughly 86% from its peak as the “crypto treasury” boom deflated. Los Angeles Times As of midday on December 11, 2025, SBET trades around $11.36 per share, with a 52‑week range of $2.26 to $124.12, a market cap of about $2.23 billion, and a beta near 12, putting it firmly in the “strap-in-and-hold-on” category of volatility. StockAnalysis Below is a deep
11 December 2025
·····
Synopsys (SNPS) Stock Outlook After November 21, 2025: Nvidia’s $2 Billion Bet, Q4 Beat, Job Cuts and Class Actions

Synopsys (SNPS) Stock Outlook After November 21, 2025: Nvidia’s $2 Billion Bet, Q4 Beat, Job Cuts and Class Actions

Synopsys, Inc. (NASDAQ: SNPS) has gone from a bruising late‑summer selloff to a high‑stakes recovery story driven by artificial intelligence, a $2 billion strategic investment from Nvidia, record revenue and a flurry of securities class‑action lawsuits. As of 11 December 2025, Synopsys stock trades around the mid‑$460s–$470s, giving the company a market cap in the high‑$80 billion range.CompaniesMarketCap+1 That’s roughly 20% above its 21 November close near $388, but still well below its 52‑week high around $652 set in late July.Yahoo Finance+1 From 21 November onward, new lawsuits, restructuring plans and blockbuster partnerships have reshaped the Synopsys narrative. Here’s what
11 December 2025
·····
Mastercard Stock Outlook After November 21, 2025: Earnings Strength, Swipe-Fee Settlement and Fresh Analyst Upgrades

Mastercard Stock Outlook After November 21, 2025: Earnings Strength, Swipe-Fee Settlement and Fresh Analyst Upgrades

Mastercard Incorporated (NYSE: MA) has been quietly grinding higher since late November, powered by robust third‑quarter results, a landmark swipe‑fee settlement with U.S. merchants, and a wave of bullish analyst calls. As of December 11, 2025, Mastercard trades around $556 per share, up roughly 3% from its $540.40 close on November 21. Mastercard Investor Relations That might not sound dramatic, but under the surface a lot has changed in how Wall Street and regulators are thinking about the card network — and those shifts matter for long‑term investors. Mastercard Stock Snapshot Since November 21, 2025 Fundamentally, Mastercard remains a premium‑valued
11 December 2025
····
Nuvation Bio (NUVB) Soars After $18 Price-Target Hike – Is This High‑Growth Cancer Stock Still a Buy in 2025?

Nuvation Bio (NUVB) Soars After $18 Price-Target Hike – Is This High‑Growth Cancer Stock Still a Buy in 2025?

Nuvation Bio Inc. (NYSE: NUVB) has quietly morphed from an obscure penny stock into one of 2025’s wildest oncology stories. As of December 11, 2025, the stock is trading in the high single digits (around $7.8–$8.0), up roughly 200% year‑to‑date, following a string of clinical wins, a first drug approval, and a wave of fresh analyst upgrades. TipRanks+1 The latest jolt came today, when H.C. Wainwright raised its 12‑month price target on NUVB from $10 to $18 while reiterating a Buy / Strong Buy rating – implying well over 100% upside from recent levels. Investing.com+1 Here’s a deep dive into
11 December 2025
·····
Centene (CNC) Stock Jumps on Baird Upgrade: What December 11, 2025 Means for the Outlook and Forecasts

Centene (CNC) Stock Jumps on Baird Upgrade: What December 11, 2025 Means for the Outlook and Forecasts

Centene Corporation (NYSE: CNC) has snapped back into the spotlight. On December 11, 2025, Centene stock surged above $40 after Robert W. Baird lifted its price target from $28 to $36 while maintaining a neutral rating. The move added to a sharp multi-week rebound following a brutal summer of guidance cuts, goodwill impairments and a rare quarterly loss. MarketBeat+1 At Thursday’s close, CNC traded around $40.73, up roughly 5.3% on the day, with an intraday high near $40.90. MarketBeat That rally puts shares about 62% above their 52‑week low of $25.08, but still roughly 39% below the 52‑week high of
11 December 2025
·····
Spotify Stock (SPOT) Outlook 2026: Price Hikes, Music Videos and Wrapped 2025 Fuel a New Phase for Investors

Spotify Stock (SPOT) Outlook 2026: Price Hikes, Music Videos and Wrapped 2025 Fuel a New Phase for Investors

Spotify Technology S.A. (NYSE: SPOT) is closing out 2025 with a flurry of headlines: a blockbuster Wrapped campaign, a fresh push into music videos, and another round of subscription price hikes on the way. At the same time, analysts remain broadly bullish, even as some warn that valuation is starting to look stretched. As of December 11, 2025, Spotify shares trade around $602.85 on the NYSE. Since November 21, 2025, when the stock closed near $583.61, SPOT has added roughly 3–4%, extending a multi‑year rally that has turned the streaming platform into one of the market’s most closely watched growth
11 December 2025
····
Vera Therapeutics (VERA) Stock Outlook: December 11, 2025 Update on Public Offering, Atacicept BLA and Wall Street Targets

Vera Therapeutics (VERA) Stock Outlook: December 11, 2025 Update on Public Offering, Atacicept BLA and Wall Street Targets

Vera Therapeutics, Inc. (NASDAQ: VERA) is back center stage on December 11, 2025, as traders digest a fresh equity offering, strong late‑stage clinical data, and a newly filed Biologics License Application (BLA) for its lead drug, atacicept, in IgA nephropathy (IgAN). During Thursday’s session, VERA shares were trading around $46, up roughly 3–4% on the day and near 52‑week highs, leaving the company with a market capitalization of about $2.9–3.0 billion.Stock Titan Below is a full rundown of the latest news, forecasts, and analysis as of December 11, 2025. Vera Therapeutics stock today: price action and technical backdrop VERA has
11 December 2025
·····
Coinbase Stock (COIN) Outlook After November 21: Analyst Targets, New Partnerships and Q3 Beat Shape the 2025–2026 Forecast

Coinbase Stock (COIN) Outlook After November 21: Analyst Targets, New Partnerships and Q3 Beat Shape the 2025–2026 Forecast

December 11, 2025 Coinbase Global, Inc. (NASDAQ: COIN) has had a turbulent few weeks, even by crypto standards. After a strong run into late October and early November, the stock has been in “reset mode,” trading in the high‑$260s on the morning of December 11, 2025. That’s roughly an 11% slide over the past month and about 14% over three months, even as crypto trading activity remains elevated. StockAnalysis+1 At the same time, Coinbase has delivered a big Q3 earnings beat, announced a landmark partnership with PNC Bank, chosen Chainlink’s CCIP as the exclusive bridge for its wrapped assets, and
11 December 2025
···
Unity Software (NYSE: U) Stock Outlook: Analyst Upgrades, Q3 Beat and 2026 Forecasts Fuel a High‑Beta Rally

Unity Software (NYSE: U) Stock Outlook: Analyst Upgrades, Q3 Beat and 2026 Forecasts Fuel a High‑Beta Rally

Updated: December 11, 2025 Unity Software Inc. (NYSE: U) has turned into one of 2025’s loudest comeback stories in software. After collapsing from its 2021 metaverse peak and alienating game developers with a disastrous pricing overhaul, the stock has roared back on the back of an AI‑driven ad business, tighter cost control and a wall of bullish analyst calls. As of late-morning trading on December 11, Unity shares are hovering around $51, near a fresh 52‑week high, giving the company a market cap of roughly $22 billion. StockAnalysis+1 That rally has invited a simple but uncomfortable question: is Unity now
11 December 2025
····
1 … 25 26 27 28 29 … 69

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Go toTop